Recruiting

Patient-Centered QOL

Sponsor:

WellSpan Health

Code:

NCT07433660

Conditions

Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative

Cancer (Solid Tumors)

Cancer (With or Without Metastasis)

Cancer - Ovarian

Cancer Abdomen

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences.

This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.

Conditions

Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative

Cancer (Solid Tumors)

Cancer (With or Without Metastasis)

Cancer - Ovarian

Cancer Abdomen

Study ID

NCT07433660

Start date

Feb, 2026

Status verified date

Feb, 2026

Completion date

Dec, 2031

Anticipated

Primary completion date

Feb, 2031

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age 18 years and above
  • Primary cancer diagnosis (newly diagnosed within the past 6 months)
  • Able to sign informed consent.

Exclusion Criteria:

  • Patients with age<18 years,
  • Patients with primary non-melanoma skin, neurological malignancies (Brain or brain metastases), and primary hematological malignancies.
  • Patients with severe cognitive impairment, unable to sign informed consent or unable to complete quality of life questionnaire.
  • Patients with life expectancy of <90 days, in the opinion of treating investigator.

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Arms

Patients Diagnosed with primary cancer in past 6 months

Patients Diagnosed with primary cancer in past 6 months will be divided into Race, ethnicity and gender and will be looked for differences in quality of life based on these subsets.

Primary outcome measure

  • Quality of Life Differences based on Race or Ethnicity or Gender [ Time Frame: Baseline, 6-12-18-24 months ]

Central Contacts and Locations

Central contacts

Joan K Moore, MSN, RN, OCN, CCRP

717-741-8124jmoore@wellspan.org

Rahul Kashyap, MBBS, MBA, FCCM

717-851-4611rkashyap@wellspan.org

Locations

WellSpan Medical Oncology & Hematology

Recruiting

Chambersburg, Pennsylvania, United States, 17201

Contacts

WellSpan Ephrata Cancer Center

Recruiting

Ephrata, Pennsylvania, United States, 17522

Contacts

WellSpan Adams Cancer Center

Recruiting

Gettysburg, Pennsylvania, United States, 17325

Contacts

WellSpan Sechler Family Cancer Center

Recruiting

Lebanon, Pennsylvania, United States, 17042

Contacts

WellSpan York Cancer Center

Recruiting

York, Pennsylvania, United States, 17403

Contacts

Joan K Moore, MSN, RN, OCN, CCRP

717-741-8124jmoore@wellspan.org

Rahul Kashyap, MBBS, MBA, FCCM

717-851-4611rkashyap@wellspan.org

More Information

Sponsor

WellSpan Health

Last update posted

Mar 2, 2026

Last verified

Feb, 2026

Keywords

  • Cancer
  • Quality of Life
  • QOL
  • Registry
  • Patient

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by WellSpan Health on 2026-03-02.